- Home
- EDSA vs RSSS Comparison
EDSA vs RSSS Comparison
Compare EDSA & RSSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EDSA | RSSS |
|---|---|---|
| Founded | 2015 | 2006 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 67.5M | 77.3M |
| IPO Year | 2018 | 2008 |
Fundamental Metrics
Financial Performance| Metric | EDSA | RSSS |
|---|---|---|
| Price | $6.86 | $2.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $5.00 | $5.00 |
| AVG Volume (30 Days) | ★ 101.0K | 42.2K |
| Earning Date | 05-08-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 130.77 |
| EPS | N/A | ★ 0.07 |
| Revenue | N/A | ★ $28,793,922.00 |
| Revenue This Year | N/A | $1.81 |
| Revenue Next Year | N/A | $5.73 |
| P/E Ratio | ★ N/A | $33.07 |
| Revenue Growth | N/A | ★ 2.77 |
| 52 Week Low | $0.72 | $2.00 |
| 52 Week High | $20.32 | $4.12 |
Technical Indicators
Market Signals| Indicator | EDSA | RSSS |
|---|---|---|
| Relative Strength Index (RSI) | 45.58 | 50.80 |
| Support Level | $4.87 | $2.17 |
| Resistance Level | $9.00 | $2.39 |
| Average True Range (ATR) | 0.67 | 0.07 |
| MACD | 0.05 | 0.00 |
| Stochastic Oscillator | 14.38 | 53.85 |
Price Performance
Historical ComparisonAbout EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
About RSSS Research Solutions Inc
Research Solutions Inc is a holding company. The company provides vertical software-as-a-service ("SaaS") and artificial intelligence ("AI") solutions, providing software and related services to help research-intensive organizations simplify the research process, save time, and money. The company operates in a single segment, which derives its revenue from subscription fees from its cloud-based SaaS Platforms and transactional service fees for the electronic delivery of single articles. The company generates the majority of its revenue from the Transactions. Geographically, the company generates the majority of its revenue from the United States, followed by Europe.